Fluorescent Biosensors: Latest Advancements, Applications, and Challenges

Fluorescent biosensors, while powerful tools for studying biological processes, still face significant challenges in achieving optimal performance, such as maximizing dynamic range, photostability, and multiplexing capabilities, which has inspired researchers to explore innovative strategies like semisynthetic probes and signal amplification techniques to overcome these limitations

Fluorescence-based biosensors are analytical devices that utilize the properties of fluorescent molecules to detect and quantify biological interactions. These biosensors work by incorporating fluorescent labels that emit light when excited by a specific wavelength. The fundamental process involves a fluorescent probe that binds to a target molecule, leading to changes in the fluorescence intensity, wavelength, or polarization. This change is measurable and directly correlates to the concentration of the target analyte in the sample.

The operation of fluorescence-based biosensors often involves three main components: the fluorescent reporter molecule, a binding element (such as antibodies, peptides, or aptamers), and a target analyte. When the target analyte interacts with the binding element, the fluorescent reporter’s environment changes, altering its optical properties. This alteration is detected and quantified using a fluorometer, which measures the intensity of the emitted light. The intensity or the shift in emission properties provides quantitative and qualitative data about the presence and concentration of the target molecule.

One common design involves Förster Resonance Energy Transfer (FRET), where two fluorescent proteins are used as a FRET pair. Upon binding of the analyte to the sensing domain, a conformational change occurs, altering the distance or orientation between the two fluorescent proteins, leading to a change in the FRET efficiency and the ratio of the donor and acceptor fluorescence intensities⁴. Alternatively, single fluorescent protein-based biosensors utilize circularly permuted fluorescent proteins (cpFPs), where the analyte binding induces a conformational change that modulates the fluorescence intensity of the cpFP⁴.

Fluorescent biosensors have been developed for various targets, including neurotransmitters, hormones, metabolites, and ions. For instance, calcium biosensors employ a calcium-binding domain fused to a fluorescent protein, where calcium binding induces a conformational change, altering the fluorescence signal³. Similarly, biosensors for neurotransmitters like glutamate, GABA (Gamma-aminobutyric acid ), and acetylcholine utilize binding proteins or receptors as the sensing domain⁴.

Recent advancements involve the use of semisynthetic probes, where self-labeling protein tags covalently bind to synthetic fluorescent ligands, offering advantages such as improved photostability and easier modification compared to fluorescent protein-based biosensors⁵. These biosensors have been developed for various targets, including metabolites, protein aggregation, DNA methylation, and cellular processes like endocytosis and membrane tension⁵.

The fluorescence signal from these biosensors can be detected and quantified using techniques like fluorescence microscopy, plate readers, or miniaturized microscopes, enabling real-time monitoring of biological processes in living cells or organisms with high spatiotemporal resolution^1,2,4.

These sensors are highly sensitive and selective, making them useful in various applications, including medical diagnostics, environmental monitoring, and food safety assessments. One of the advantages of fluorescence-based biosensors is their ability to provide real-time and non-invasive measurements, which is crucial for dynamic biological processes. However, they can be susceptible to background fluorescence and require careful calibration and setup to ensure accuracy.

Latest Developments in Fluorescence based Biosensors and their advantages

The latest developments in fluorescence-based biosensors involve the use of semisynthetic probes, which combine the advantages of fluorescent proteins and synthetic fluorophores. These biosensors utilize self-labeling protein tags that covalently bind to synthetic fluorescent ligands, offering improved photostability, easier modification, and expanded spectral options compared to traditional fluorescent protein-based biosensors^7,8. Some key advancements and applications of these semisynthetic fluorescent biosensors include:

1. Metabolite sensing: Biosensors have been developed for monitoring various metabolites like NAD+, ATP, and glucose in living cells, enabling real-time tracking of metabolic processes⁷.
2. Protein aggregation and degradation: Sensors can detect and visualize protein aggregation associated with neurodegenerative diseases, as well as monitor protein degradation pathways⁷.
3. DNA methylation: Fluorescent biosensors can map DNA methylation patterns, which are crucial epigenetic markers linked to gene expression and diseases⁷.
4. Endocytosis and exocytosis: These sensors can track endocytic and exocytic processes, providing insights into cellular trafficking mechanisms⁷
5. Membrane tension and cellular viscosity: Biosensors have been developed to monitor changes in membrane tension and cellular viscosity, which are important parameters in cellular physiology⁷.

The main advantages of semisynthetic fluorescent biosensors include:

1. Improved photostability and brightness compared to fluorescent proteins⁷.
2. Facile modification and spectral tuning by using different synthetic fluorophores⁷.
3. Smaller size and better tissue penetration compared to fluorescent proteins⁷.
4. Ability to multiplex and simultaneously monitor multiple targets by using spectrally distinct probes^7,8.

Additionally, cyclic signal amplification (CSA) strategies like rolling circle amplification, strand displacement reactions, and enzyme-assisted amplification have been employed to enhance the sensitivity and detection limits of fluorescent biosensors⁶. These advancements have expanded the applications of fluorescent biosensors in various fields, including biology, medicine, food safety, and environmental monitoring^6,8.

Challenges and Limitations

Fluorescence-based biosensors, while offering numerous advantages, still face several challenges and limitations. One major limitation is the inherent trade-off between brightness and dynamic range, as brighter fluorescent proteins often exhibit smaller dynamic ranges⁹. Additionally, the photostability of fluorescent proteins can be a concern, particularly for long-term imaging experiments⁹. Achieving far-red or near-infrared fluorescence, which is desirable for deep tissue imaging, remains a challenge for fluorescent protein-based biosensors⁹.

Another limitation is the difficulty in developing biosensors with optimal affinities for their targets within the biologically relevant range⁹. Furthermore, the availability of suitable transcription factor-promoter pairs for constructing transcription factor-based biosensors is limited, restricting the range of targets that can be detected¹⁰.

Multiplexed imaging, which involves simultaneously monitoring multiple targets, is often hindered by the spectral overlap of fluorescent proteins and the limited number of spectrally distinct fluorescent proteins available^9,11. This limitation has prompted researchers to explore alternative strategies, such as the use of self-labeling protein tags that can incorporate synthetic fluorophores with diverse spectral properties^9,11.

Another challenge lies in the development of biosensors that can function effectively in complex biological environments, such as living cells or tissues, where factors like pH, ionic strength, and the presence of interfering molecules can affect biosensor performance¹⁰.

Moreover, the sensitivity and detection limits of fluorescent biosensors can be a limitation, particularly for detecting low-abundance targets¹¹. To address this, researchers have explored signal amplification strategies, such as cyclic signal amplification (CSA) techniques like rolling circle amplification, strand displacement reactions, and enzyme-assisted amplification¹¹. However, these strategies can introduce additional complexity and potential sources of interference¹¹.

Finally, the optimization and development of highly efficient biosensors often require significant time and resources, as exemplified by the decades-long effort to develop the highly optimized GCaMP series of calcium biosensors⁹. Researchers are actively exploring strategies to accelerate the pace of biosensor development and optimization, such as high-throughput screening methods and directed evolution approaches⁹.